A phase I study comparing the pharmacokinetics of the biosimilar (RD12014) with liraglutide (Victoza) in healthy Chinese male subjects

Zhou, RR; Guo, LF; Gao, XL; Wang, YJ; Xu, WJ; Zou, Y; Li, WJ; Zhuang, YL; Liu, GY; Liu, YM

Liu, GY; Liu, YM (通讯作者)，Shanghai Xuhui Cent Hosp, Cent Lab, 966 Huaihai Rd M, Shanghai 200031, Peoples R China.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022; 15 (10): 2458

Abstract

This study aimed to evaluate the pharmacokinetics (PKs), safety, and immunogenicity of the biosimilar (RD12014) compared to reference liraglutide (Vic......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索